BRADLEY PHARMACEUTICALS INC
4, 2000-08-10
PHARMACEUTICAL PREPARATIONS
Previous: CNL INCOME FUND X LTD, 10-Q, EX-27, 2000-08-10
Next: BRADLEY PHARMACEUTICALS INC, 4, EX-1, 2000-08-10



____Check this box if no longer subject to Section 16. Form 4 or Form 5
    obligations may continue. See Instruction 1(b).

                      U.S. SECURITIES AND EXCHANGE COMMISSION
                                  Washington, D.C. 20549

                                         FORM 4

                   STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange act of 1934,
Section 17(a) of the Public Utility Holding Company act of 1935 or Section
30(f) of the Investment Company Act of 1940

1. Name and Address of Reporting Person

   Glassman    Daniel
    (Last)    (First)     (Middle)

  	383 Route 46 West
      (Street)

   Fairfield     NJ       07004
    (City)    (State)     (Zip)

2. Issuer Name and Ticker or Trading Symbol		"BPRX"

   BRADLEY PHARMACEUTICALS, INC.

3. IRS or Social Security Number of Reporting Person (Voluntary)

4. Statement for Month/Year			               	07/2000

5. If Amendment, Date of Original (Month/Year)

6. Relationship of Reporting Person to Issuer (Check all applicable)

  	__X__Director                               __X__10 % Owner
  	__X__Officer (give title                    _____Other (specify below)
                 below)

                         Chairman, Pres. & CEO

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially
          Owned

1. Title of Security (Instr.3)
         (1)  	Common Stock
         (2)  	Common Stock
         (3)  	Common Stock
         (4)  	Common Stock Transferred to Bradley Glassman Form 3
         (5)  	Common Stock
         (6)  	Common Stock Transferred to Bradley Glassman Form 3
         (7)  	Class B Common Stock
         (8)  	Class B Common Stock
         (9)  	Class B Common Stock
         (10)  Class B Common Stock
         (11)  Common Stock
         (12)  Common Stock
         (13)  Class B Common Stock
         (14)  Common Stock
         (15)  Common Stock
         (16)  Class B Common Stock
         (17)  Common Stock
         (18)  Common Stock
         (19)  Common Stock Transferred to Bradley Glassman Form 3
         (20)  Common Stock
         (21)  Common Stock
         (22)  Common Stock Transferred to Bradley Glassman Form 3
         (23)  Common Stock
2. Transaction Date (Month/Day/Year)
         (1)
         (2)
         (3)
         (4)   07/31/00
         (5)
         (6)   07/31/00
         (7)
         (8)
         (9)
         (10)
         (11)
         (12)
         (13)
         (14)
         (15)
         (16)
         (17)
         (18)  07/19/00
         (19)  07/31/00
         (20)  07/19/00
         (21)
         (22)  07/31/00
         (23)
3. Transaction Code (Instr.8)
         (1)
         (2)
         (3)
         (4)   Code J
         (5)
         (6)   Code J
         (7)
         (8)
         (9)
         (10)
         (11)
         (12)
         (13)
         (14)
         (15)
         (16)
         (17)
         (18)  Code T
         (19)  Code J
         (20)  Code T
         (21)
         (22)  Code J
         (23)
4. Securities Acquired (A) or Disposed of (D) (Instr. 3,4 and 5)
         (1)
         (2)
         (3)
         (4)   Amount -  3,000 (D)	  Price - 0
         (5)
         (6)   Amount -  5,266 (D)  	Price - 0
         (7)
         (8)
         (9)
         (10)
         (11)
         (12)
         (13)
         (14)
         (15)
         (16)
         (17)
         (18)  Amount -    485 (A)  	Price - 1.2655
         (19)  Amount - 10,265 (D)  	Price - 0
         (20)  Amount -    385 (A)   Price - 1.2655
         (21)
         (22)  Amount -  1,942 (D)  	Price - 0
         (23)
5. Amount of Securities Beneficially Owned at End of Month (Instr. 3 and 4)
         (1)     1,600
         (2)     8,300
         (3)    14,500
         (4)       -
         (5)    17,500
         (6)       -
         (7)   280,838
         (8)    16,005
         (9)       360
         (10)   16,403
         (11)    4,100
         (12)    2,267
         (13)    9,733
         (14)   15,350
         (15)   30,000
         (16)   13,400
         (17)      968
         (18)   11,390
         (19)      -
         (20)    6,529
         (21)    2,147
         (22)      -
         (23)    1,811
6. Ownership Form: Direct (D) or Indirect (I)
         (1)   (D)
         (2)   (I)
         (3)   (I)
         (4)   (I)
         (5)   (I)
         (6)   (I)
         (7)   (D)
         (8)   (I)
         (9)   (I)
         (10)  (I)
         (11)  (D)
         (12)  (I)
         (13)  (I)
         (14)  (D)
         (15)  (D)
         (16)  (D)
         (17)  (I)
         (18)  (I)
         (19)  (I)
         (20)  (I)
         (21)  (I)
         (22)  (I)
         (23)  (I)
7. Nature of Indirect Beneficial Ownership (Instr. 4)
         (1)
         (2)   By DLD Partners
         (3)   By IRA
         (4)   By Children
         (5)   By IRA
         (6)   By Children
         (7)
         (8)   By Banyan Communications Group, Inc.
         (9)   By DLD Partners
         (10)  By Spouse
         (11)  With Spouse
         (12)  By 5G's Partnership
         (13)  By 5G's Partnership
         (14)  With Spouse
         (15)  With Spouse
         (16)  With Spouse
         (17)  By Children
         (18)  By 401(k)
         (19)  By Children
         (20)  By Children
         (21)  By 401(k) Match
         (22)  By 401(k) Match By Children
         (23)  By 401(k) Match By Children

Reminder: Report on a separate line for each class of securities beneficially
          owned directly or indirectly.
                               (Print or Type Responses)

FORM 4 (continued)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
           (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr.3)
        	Options (right to buy)
2. Conversion or Exercise Price of Derivative Security
         (1)   1.44375
         (2)   1.44375
         (3)   1.44375
         (4)   1.16875
         (5)   1.16875
         (6)   1.16875
         (7)    .82500
         (8)   1.99375
         (9)   1.99375
         (10)  1.99375
         (11)  2.06875
         (12)  1.16875
         (13)  1.44375
         (14)  1.44375
         (15)  1.44375
3. Transaction Date (Month/Day/Year)
4. Transaction Code (Instr.8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
   (Instr.3,4 and 5)
6. Date Exercisable and Expiration Date (Month/Day/Year)
         (1)   Exercisable - 09/12/96  	Expiration - 09/11/00
         (2)   Exercisable - 09/12/97	  Expiration - 09/11/00
         (3)   Exercisable - 09/12/98	  Expiration - 09/11/00
         (4)   Exercisable - 10/26/00	  Expiration - 10/25/04
         (5)   Exercisable - 10/26/01	  Expiration - 10/25/04
         (6)   Exercisable - 10/26/02	  Expiration - 10/25/04
         (7)   Exercisable - 12/05/96	  Expiration - 12/04/01
         (8)   Exercisable - 01/27/99	  Expiration - 01/26/03
         (9)   Exercisable - 01/27/00	  Expiration - 01/26/03
         (10)  Exercisable - 01/27/01	  Expiration - 01/26/03
         (11)  Exercisable - 06/09/98  	Expiration - 06/08/03
         (12)  Exercisable - 12/05/95	  Expiration - 12/04/00
         (13)  Exercisable - 01/21/00	  Expiration - 01/20/04
         (14)  Exercisable - 01/21/01   Expiration - 01/20/04
         (15)  Exercisable - 01/21/02	  Expiration - 01/20/04
7. Title and Amount of Underlying Securities
         (1)   Title - Common Stock    	Number of Shares -   6,000
         (2)   Title - Common Stock	    Number of Shares -   6,000
         (3)   Title - Common Stock	    Number of Shares -   6,000
         (4)   Title - Common Stock	    Number of Shares -  50,000
         (5)   Title - Common Stock	    Number of Shares -  50,000
         (6)   Title - Common Stock	    Number of Shares -  50,000
         (7)   Title - Common Stock     Number of Shares -  31,500
         (8)   Title - Common Stock	    Number of Shares -   8,333
         (9)   Title - Common Stock	    Number of Shares -   8,333
         (10)  Title - Common Stock	    Number of Shares -   8,334
         (11)  Title - Common Stock	    Number of Shares -  30,000
         (12)  Title - Common Stock	    Number of Shares - 341,589
         (13)  Title - Common Stock    	Number of Shares -  50,000
         (14)  Title - Common Stock    	Number of Shares -  50,000
         (15)  Title - Common Stock	    Number of Shares -  50,000
8. Price of Derivative Security (Instr. 5)
         (1)   1.44375
         (2)   1.44375
         (3)   1.44375
         (4)   1.16875
         (5)   1.16875
         (6)   1.16875
         (7)    .82500
         (8)   1.99375
         (9)   1.99375
         (10)  1.99375
         (11)  2.06875
         (12)  1.16875
         (13)  1.44375
         (14)  1.44375
         (15)  1.44375
9. Number of Derivative Securities Beneficially Owned at End of Month
   (Instr. 4)
         (1)     6,000
         (2)     6,000
         (3)     6,000
         (4)    50,000
         (5)    50,000
         (6)    50,000
         (7)    31,500
         (8)     8,333
         (9)     8,333
         (10)    8,334
         (11)   30,000
         (12)  341,589
         (13)   50,000
         (14)   50,000
         (15)   50,000
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
    (Instr.4)
         (D)
11. Nature of Indirect Beneficial Ownership (Instr.4)


Explanation of Responses:
Note: 401(k) Match subject to a vesting schedule of 20% for each completed
      year of service.


                                 /s/Daniel Glassman	         August 9, 2000
                          -------------------------------    --------------
                         	**Signature of Reporting Person	         Date

**	Intentional misstatements or omissions of facts constitute Federal Criminal
   Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note:	File three copies of this Form, one of which must be manually signed.
      If space provided is insufficient, see Instruction 6 for procedure.

                                                            	SEC 1474 (3/91)



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission